ArticleBlood advances2020
Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia.
Abstract read
In one paragraph
Article in Blood advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?Leukemia · 2026Trial
- Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 study.Blood neoplasia · 2025Trial
- CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model ofCancer biology & therapy · 2026Article
- Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification.Current hematologic malignancy reports · 2026Review
- An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study.Cancer science · 2026Article
- Mechano-induced patterned domain formation by monocytes.Nature materials · 2026Article
- Plasmacytoid dendritic cell proliferations, malignant histiocytic (macrophage/dendritic cell) neoplasms and follicular dendritic cell neoplasms: report from the 2024 Joint CSHP/EA4HP/SH workshop.Virchows Archiv : an international journal of pathology · 2025Article
- Plasmacytoid dendritic cell clusters are associated with poor prognosis in chronic myelomonocytic leukemia.Virchows Archiv : an international journal of pathology · 2025Article
- Chronic Myelomonocytic Leukemia Microenvironment in Disease Progression and Therapy: Focus on Stepwise Reconfiguring of Myeloid-Immune Cell Interactions Driving Immune Tolerance.Current hematologic malignancy reports · 2025Review
- Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience.Oncotarget · 2025Article
- Article
- Diagnostic features in paediatric MDS-EB with UBTF-internal tandem duplication: defining a unique subgroup.Histopathology · 2025Article
- Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations.Haematologica · 2025Review
- Review
- Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.Leukemia · 2021Article
- Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia.Leukemia · 2021Review
- Differential Diagnosis and Workup of Monocytosis: A Systematic Approach to a Common Hematologic Finding.Current hematologic malignancy reports · 2021Review
- Treatment advances for pediatric and adult onset neoplasms with monocytosis.Current hematologic malignancy reports · 2021Review
- Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis - Chronic Myelomonocytic Leukemia and Beyond.Current hematologic malignancy reports · 2021Review
- Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia.The oncologist · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Abhishek A MangaonkarDivision of Hematology, Department of Medicine, and.
Kaaren K ReichardDivision of Hematopathology, Mayo Clinic, Rochester, MN.
Moritz BinderDivision of Hematology, Department of Medicine, and.
Giacomo ColtroHaematology Unit and.
Terra L LashoDivision of Hematology, Department of Medicine, and.
Ryan M CarrDivision of Hematology, Department of Medicine, and.
April ChiuDivision of Hematopathology, Mayo Clinic, Rochester, MN.
Vivian NegronPathology Research Core, Department of Pathology, Mayo Clinic, Rochester, MN.
Mehrdad HefaziDivision of Hematology, Department of Medicine, and.
Theodora AnagnostouBone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; and.
Michael M TimmDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
James W HiebertDivision of Hematology, Department of Medicine, and.
Jose C VillasboasDivision of Hematology, Department of Medicine, and.
Wilson I GonsalvesDivision of Hematology, Department of Medicine, and.
Naseema GangatDivision of Hematology, Department of Medicine, and.
Mithun ShahDivision of Hematology, Department of Medicine, and.
Hassan B AlkhateebDivision of Hematology, Department of Medicine, and.
Aref Al-KaliDivision of Hematology, Department of Medicine, and.
Michelle A ElliottDivision of Hematology, Department of Medicine, and.
Kebede H BegnaDivision of Hematology, Department of Medicine, and.
Alexandra P Wolanskyj-SpinnerDivision of Hematology, Department of Medicine, and.
Mark R LitzowDivision of Hematology, Department of Medicine, and.
William J HoganDivision of Hematology, Department of Medicine, and.
Stephen M AnsellDivision of Hematology, Department of Medicine, and.
Animesh PardananiDivision of Hematology, Department of Medicine, and.
Ayalew TefferiDivision of Hematology, Department of Medicine, and.
Mrinal M PatnaikDivision of Hematology, Department of Medicine, and.
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MMayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4MNCATS NIH HHS UL1 TR002377NCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Indexed as
Leukemia, Myelomonocytic, ChronicBone MarrowBone Marrow CellsDendritic CellsHumans
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.